The current valuation score of Rigel Pharmaceuticals Inc is 8.58, ranking 79 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 1.63, which is 1407.51% below the recent high of 24.52 and 6946.00% above the recent low of -111.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.